Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Neurology
16 active people
173 grants
Recent Grants
Expanding AD Biomarkers in NIA funded PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Tria
2024
·
$1.8M
biomarkers,
menopause,
brain metabolism,
cognition,
clinical trial
Disrupted Lipid Metabolism in Alzheimer's Disease
2024
·
$1.6M
alzheimer's disease,
lipid metabolism,
brain health,
neurodegeneration,
metabolic disorders
Study to Evaluate Safety, Efficacy and Tolerability of ABBV-950 for the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
2024
·
$822.1K
stroke rehabilitation,
spasticity treatment,
drug safety,
efficacy evaluation,
tolerability assessment
PNA5, an Angiotensin-(1-7) Glycopeptide, to Treat Dementia in Parkinson's Disease
2024
·
$518.6K
neuroscience,
pharmacology,
dementia,
parkinson's,
therapeutics
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
2024
·
$440.6K
epilepsy,
medication,
clinical trial,
adjunctive therapy,
safety
APOE Regulation of Neuron-Astrocyte Metabolic Coupling in Alzheimer's Disease
2024
·
$378.5K
alzheimer's disease,
metabolic coupling,
neuron-astrocyte interactions,
apoe regulation,
neurodegeneration
A Multi-Center, Phase IIA, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects
2024
·
$303.6K
ketamine,
dyskinesia,
levodopa,
clinical trial,
anesthetic infusion
Infection and Inflammation as Drivers of Aging (IIDA) Predoctoral Training Program
2024
·
$292.3K
aging,
infection,
inflammation,
pre-doctoral,
training
Diversity in Research Education in Aging Medicine and Science
2024
·
$288.3K
diversity,
education research,
aging,
medicine,
science
Neuroscience Diversity to Elevate Education and Research Development
2024
·
$269.2K
neuroscience,
diversity,
education,
research development
Patient-Based Postmortem Fibroblast Banking for Translational Research
2024
·
$30K
translational research,
biobanking
A Phase 2, multicenter, Open-Label, Long-Term Safety Study of LP352 in Subjects with Developmental and Epileptic Encephalopathy who Completed Study LP352-201 and are Candidates for Continuous Treatmen
2024
·
$19.8K
epileptic encephalopathy,
long-term safety,
developmental disorders,
continuous treatment
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: An FDA Required Toxicology
2023
·
$3.9M
cognitive impairment,
vascular dementia,
alzheimer's disease,
mas receptor agonist,
toxicology
A Treatment for Neuropsychological and Memory Impairments Following Moderate to Severe Traumatic Brain Injury
2023
·
$3M
neuropsychology,
memory impairments,
traumatic brain injury,
treatment,
cognitive rehabilitation
A First-in-human (FIH) Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
2023
·
$749.8K
neuroscience,
epilepsy,
clinical trial,
drug resistance,
inhibitory interneurons
Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease
2023
·
$597.6K
parkinson's disease,
dose escalation,
clinical trial,
neurodegenerative diseases
A Phase 1b/2a Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy
2023
·
$543.6K
clinical trials,
pharmacology,
safety,
efficacy,
dose escalation
Identifying Human Neuron IFN-y Dependent Anti-Toxoplasma Gondii Responses
2023
·
$422.1K
neurobiology,
immunology,
infectious disease,
cell biology,
neuroimmunology
A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study in Parkinson?s Disease Patients With Dyskinesia to Assess the Efficacy and Safety/Tolerability of Fixed Dose Combinations of JM-010 and i
2023
·
$308.7K
parkinson's disease,
dyskinesia,
efficacy,
safety/tolerability
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
2023
·
$275.7K
alzheimer disease,
natural products,
dementia,
treatment,
combinations
People
Anita Koshy
Professor
Bruce Coull
Vice Dean
Francesca Vitali
Assistant Professor
Gerson Hernandez
Senior Director
Alex Hishaw
Associate Professor
Holli Horak
Professor
David Labiner
Department Head
Linda Restifo
Professor
Lalitha Madhavan
Associate Professor
Mandi Corenblum
Research Technologist II
Adriana O'Dell
Medical Education Program Professional I
Rui Chang
Associate Professor
Scott Sherman
Professor
Torsten Falk
Research Professor
Vijayan Ramachandran
Scientific Analyst II
Kuixi Zhu
Research Specialist, Principal
Funding support
14 funding agencies since 2020
Research expenses history
